Consultation Hub

Welcome to the Consultation Hub. This site will help you find, share and participate in consultations that interest you. Below you will find links to the consultations we are currently running.

Alternatively you may search for consultations by keyword, interest or status. Once finalised, decisions will be published under Closed Consultations.

Open Consultations

  • Include COVID-19 Chapter in the Australian Immunisation Handbook

    The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders to include the COVID-19 chapter in the Australian Immunisation Handbook, with an intention to submit the revised chapter to the National Health and Medical Research Council (NHMRC) for its approval under...

    Closes today

  • Weekly Bed Vacancy Data Request - 11 July 2025

    Please complete the data survey by close of business today. Please do not use any other to provide your data, as this impacts consolidation and analysis. This information will be submitted to the Tasmanian Health Service (THS) by close of business Monday 14 July 2025. It will...

    Closes 14 July 2025

  • National Allied Health Digital Uplift Plan Consultation

    The Australian Government Department of Health, Disability and Ageing (the Department) is developing a phased plan to uplift the digital capabilities of the allied health sector in partnership with the Australian Digital Health Agency (the Agency) and Allied Health Professions Australia (AHPA). ...

    Closes 20 July 2025

  • Survey to inform development of the National Mental Health and Suicide Prevention Peer Workforce Association

    The peer workforce in Australia has expanded significantly over time and plays an important role in the delivery of effective mental health and suicide prevention services. As outlined in the 2022-2032 National Mental Health Workforce Strategy, and the National Suicide Prevention Strategy...

    Closes 21 July 2025

  • Feedback on the draft National Health Genomics Policy Framework 2026 to 2030

    Purpose of this survey The Department of Health, Disability and Ageing is seeking your feedback on the draft National Health Genomics Policy Framework and Implementation Plan 2026 - 2030 (the draft Framework and Implementation Plan). Your input will help refine the draft Framework and...

    Closes 25 July 2025

Closed Consultations

  • Consultation on the commercial release of a genetically modified (GM) mosquito strain (DIR 207)

    The Gene Technology Regulator has received a licence application (DIR 207) from Oxitec Australia Pty Ltd for a commercial release of a genetically modified (GM) mosquito strain to help prevent dengue outbreaks. Comments are now being sought on the consultation version of the Risk Assessment...

    Closed 7 July 2025

  • Weekly Bed Vacancy Data Request - 4 July 2025

    Please complete the data survey by close of business today. Please do not use any other to provide your data, as this impacts consolidation and analysis. This information will be submitted to the Tasmanian Health Service (THS) by close of business Monday 7 July 2025. It will...

    Closed 7 July 2025

  • MPS Reforms - Implementing 24/7 RN Survey

    The purpose of this survey is to provide Multi-Purpose Services with the opportunity to provide feedback regarding the 24/7 RN trial.

    Closed 6 July 2025

  • PDSN Portal Feedback Survey

    Thank you for using the new Price Disclosure and Stockholding Notification (PDSN) Portal (the Portal). As the Portal has now been live since 9 April 2025, we’d appreciate your feedback to help us assess the benefit the Portal provides users in submitting, updating and managing likely or actual...

    Closed 30 June 2025

  • Weekly Bed Vacancy Data Request - 27 June 2025

    Please complete the data survey by close of business today. Please do not use any other to provide your data, as this impacts consolidation and analysis. This information will be submitted to the Tasmanian Health Service (THS) by close of business Monday 30 June 2025. It will...

    Closed 30 June 2025

We Asked, You Said, We Did

Here are some of the issues we have consulted on and their outcomes. See all outcomes

We asked

Earlier in 2025, over 200 participants from local government aged care providers and sector peak bodies shared their views on aged care changes.

Thank you to everyone who participated.

You said

Local government aged care providers told us they:

  • have stable and experienced workforces and many volunteers
  • often serve as a provider of last resort in rural and remote areas or for people with complex needs
  • help older people to understand the aged care system, including referrals to other support services and programs
  • have strong relationships and knowledge within their communities.

Providers raised concerns about:

  • providing aged care services with different funding arrangements, including the setting and collecting of participant contributions
  • increased costs and resources to deliver services in rural and remote areas and for people with complex needs
  • meeting community expectations to help older people navigate the aged care system and manage their cases
  • balancing local council governance and community consultation requirements, with the operational and business requirements to deliver aged care services
  • attracting and retaining staff in rural and remote areas, the cost of training and registering volunteers, and offering competitive employee wages
  • understanding the transition to the new aged care system and changes to provider obligations and funding.

We did

We are considering all feedback for future policy decisions.

If you would like to provide any further feedback on the delivery of aged care services by local governments, please contact us at AgedCareMarket@health.gov.au

We asked

Between 2 April and 13 May 2025, we sought your feedback on the consultation version of the Risk Assessment and Risk Management Plan (RARMP) prepared for the DIR 215 licence application (field trial of genetically modified canola from Miruku Australia Pty Ltd).

You said

During the 6-week consultation period, we received advice from prescribed Government agencies, the Gene Technology Technical Advisory Committee, and the public.

We heard support for:

  • the proposed limits and controls listed in the RARMP
  • the uncertainties identified in the RARMP
  • the overall conclusions of the RARMP.

Some submissions sought clarification on the potential for increased weediness as a result of the inserted fusion protein, the ability to inspect for related species, and on oversight of the proposed sensory testing.

We did

We analysed the feedback provided during the public consultation process in finalising the RARMP. The issues raised and how they were addressed can be found in Appendices A and B of the final RARMP.

The Gene Technology Regulator issued a licence to Miruku Australia Pty Ltd for their research work with the GM canola on 16 June 2025. More details, including the final version of the RARMP and the licence, are available at DIR 215 | Office of the Gene Technology Regulator.

We appreciate all those who provided input to the consultation – your feedback will help to ensure that any risks posed by gene technology to people and the environment continue to be managed.

We asked

Between 17 March to 28 April we sought your feedback on the consultation version of the Risk Assessment and Risk Management Plan (RARMP) prepared for DIR-214 licence application (Trial of a genetically modified (GM) vaccine for the prevention of respiratory disease in horses). 

You said

During the 6-week consultation period we received email advice from prescribed Government agencies and the Gene Technology Technical Advisory Committee but did not receive any public feedback.

We heard support for:

  • the thoroughness of the RARMP
  • the proposed limits and controls listed in the RARMP
  • the overall conclusions of the RARMP

We did

We analysed the feedback provided during the public consultation process and took into account submitter suggestions to improve clarity on the methods of decontamination and the origin of the genetic material inserted into the GMO in finalising the RARMP (comments addressed in Appendix A).

The Gene Technology Regulator issued a licence to The University of Queensland for their research work with the GM vaccine for horses on 4 June 2025. More details are available at DIR 214 | Office of the Gene Technology Regulator.

We appreciate all those who provided input to the consultation – your feedback will help to ensure the OGTR continues to manage any risks posed by gene technologies to people and the environment.